Thromboembolism in Pregnancy Treatment & Management

Updated: Dec 02, 2022
  • Author: Edward H Springel, MD, FACOG; Chief Editor: Ronald M Ramus, MD  more...
  • Print

Approach Considerations

See Medications.

Long-Term Monitoring

Therapeutic and prophylactic management for VTE postpartum is as mentioned previously.

Estrogen-containing contraception has been shown to increase the risk of VTE 35-99 times above baseline. [48, 49] Therefore, estrogen-based contraception is contraindicated in a patient with a VTE associated with estrogen (eg, oral estrogen containing contraceptive) or thrombophilia. Nonetheless, screening all women prior to initiating estrogen-containing contraception is not recommended by ACOG. [49, 50] Other contraceptive methods that do not include estrogen, including progestin-containing contraceptives, may be considered in women with a prior VTE or known thrombophilia. [49, 50]